The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials

J. S. Kirby, L. Thorlacius, B. Villumsen, J. R. Ingram, A. Garg, K. B. Christensen, M. Butt, S. Esmann, J. Tan, G. B.E. Jemec

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory condition that can have a large negative impact on health-related quality of life (HRQOL). A reliable and validated measure of HS-specific HRQOL in clinical studies is needed. Objectives: To develop and validate the Hidradenitis Suppurativa Quality Of Life (HiSQOL

Original languageEnglish (US)
Pages (from-to)340-348
Number of pages9
JournalBritish Journal of Dermatology
Volume183
Issue number2
DOIs
StatePublished - Aug 1 2020

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint Dive into the research topics of 'The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials'. Together they form a unique fingerprint.

  • Cite this

    Kirby, J. S., Thorlacius, L., Villumsen, B., Ingram, J. R., Garg, A., Christensen, K. B., Butt, M., Esmann, S., Tan, J., & Jemec, G. B. E. (2020). The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials. British Journal of Dermatology, 183(2), 340-348. https://doi.org/10.1111/bjd.18692